Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1111
mi
from
Richmond, VA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1111
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1408
mi
from
Bothell, WA
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1408
mi
from
Bothell, WA
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
630
mi
from
Milwaukee, WI
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
630
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated:  1/8/2016
Study Site
mi
from
Bourgas,
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Status: Enrolling
Updated: 1/8/2016
Study Site
mi
from
Bourgas,
Click here to add this to my saved trials
Treatment Development Targeting Severe and Persistent Negative Symptoms
Treatment Development Targeting Severe and Persistent Negative Symptoms
Status: Enrolling
Updated:  1/8/2016
Center for Health Care Services
576
mi
from
San Antonio, TX
Treatment Development Targeting Severe and Persistent Negative Symptoms
Treatment Development Targeting Severe and Persistent Negative Symptoms
Status: Enrolling
Updated: 1/8/2016
Center for Health Care Services
576
mi
from
San Antonio, TX
Click here to add this to my saved trials
Social Cognitive Training for Psychosis: Treatment Development
Social Cognitive Training for Psychosis: Phase I Treatment Development
Status: Enrolling
Updated:  1/11/2016
VA Connecticut Healthcare System
1343
mi
from
West Haven, CT
Social Cognitive Training for Psychosis: Treatment Development
Social Cognitive Training for Psychosis: Phase I Treatment Development
Status: Enrolling
Updated: 1/11/2016
VA Connecticut Healthcare System
1343
mi
from
West Haven, CT
Click here to add this to my saved trials
Brexpiprazole in Patients With Schizophrenia
Interventional, Open-label, Flexible-dose Extension Study of Brexpiprazole in Patients With Schizophrenia
Status: Enrolling
Updated:  1/18/2016
US009
mi
from
Escondido, CA
Brexpiprazole in Patients With Schizophrenia
Interventional, Open-label, Flexible-dose Extension Study of Brexpiprazole in Patients With Schizophrenia
Status: Enrolling
Updated: 1/18/2016
US009
mi
from
Escondido, CA
Click here to add this to my saved trials
Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia
Pilot Study of the Feasibility of a Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia
Status: Enrolling
Updated:  1/21/2016
Freedom Trail Clinic
1444
mi
from
Boston, MA
Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia
Pilot Study of the Feasibility of a Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia
Status: Enrolling
Updated: 1/21/2016
Freedom Trail Clinic
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia
Pilot Study of the Feasibility of a Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia
Status: Enrolling
Updated:  1/21/2016
Massachusetts Mental Health Center
1441
mi
from
Jamaica Plain, MA
Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia
Pilot Study of the Feasibility of a Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia
Status: Enrolling
Updated: 1/21/2016
Massachusetts Mental Health Center
1441
mi
from
Jamaica Plain, MA
Click here to add this to my saved trials
Remediation of Working Memory in Schizophrenia
Remediation of Working Memory in Schizophrenia
Status: Enrolling
Updated:  1/22/2016
Minneapolis VA Health Care System, Minneapolis, MN
548
mi
from
Minneapolis, MN
Remediation of Working Memory in Schizophrenia
Remediation of Working Memory in Schizophrenia
Status: Enrolling
Updated: 1/22/2016
Minneapolis VA Health Care System, Minneapolis, MN
548
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia
Clinical Trial to Assess Transcranial Current Stimulation as a Treatment for Medication Refractory Auditory Hallucinations in Schizophrenia
Status: Enrolling
Updated:  1/25/2016
University of North Carolina at Chapel Hill, Outpatient STEP Clinic
1043
mi
from
Chapel Hill, NC
Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia
Clinical Trial to Assess Transcranial Current Stimulation as a Treatment for Medication Refractory Auditory Hallucinations in Schizophrenia
Status: Enrolling
Updated: 1/25/2016
University of North Carolina at Chapel Hill, Outpatient STEP Clinic
1043
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia
Clinical Trial to Assess Transcranial Current Stimulation as a Treatment for Medication Refractory Auditory Hallucinations in Schizophrenia
Status: Enrolling
Updated:  1/25/2016
University of North Carolina, Wake STEP Clinic
1073
mi
from
Raleigh, NC
Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia
Clinical Trial to Assess Transcranial Current Stimulation as a Treatment for Medication Refractory Auditory Hallucinations in Schizophrenia
Status: Enrolling
Updated: 1/25/2016
University of North Carolina, Wake STEP Clinic
1073
mi
from
Raleigh, NC
Click here to add this to my saved trials
Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)
Targeted Self-Management for Epilepsy and Serious Mental Illness
Status: Enrolling
Updated:  1/27/2016
University Hospitals at Case Medical Center
898
mi
from
Cleveland, OH
Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)
Targeted Self-Management for Epilepsy and Serious Mental Illness
Status: Enrolling
Updated: 1/27/2016
University Hospitals at Case Medical Center
898
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cognitive Behavior Therapy and Work Outcome
Effects of CBT and Cognitive Remediation on Work in Schizophrenia
Status: Enrolling
Updated:  1/29/2016
Richard L. Roudebush VA Medical Center, Indianapolis, IN
643
mi
from
Indianapolis, IN
Cognitive Behavior Therapy and Work Outcome
Effects of CBT and Cognitive Remediation on Work in Schizophrenia
Status: Enrolling
Updated: 1/29/2016
Richard L. Roudebush VA Medical Center, Indianapolis, IN
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy of Pimozide Augmentation for Clozapine Partial Response
Efficacy of Pimozide Augmentation for Clozapine Partial Response
Status: Enrolling
Updated:  2/4/2016
Connecticut Mental Health Center
1344
mi
from
New Haven, CT
Efficacy of Pimozide Augmentation for Clozapine Partial Response
Efficacy of Pimozide Augmentation for Clozapine Partial Response
Status: Enrolling
Updated: 2/4/2016
Connecticut Mental Health Center
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
Efficacy of Pimozide Augmentation for Clozapine Partial Response
Efficacy of Pimozide Augmentation for Clozapine Partial Response
Status: Enrolling
Updated:  2/4/2016
VA Connecticut Healthcare System
1343
mi
from
West Haven, CT
Efficacy of Pimozide Augmentation for Clozapine Partial Response
Efficacy of Pimozide Augmentation for Clozapine Partial Response
Status: Enrolling
Updated: 2/4/2016
VA Connecticut Healthcare System
1343
mi
from
West Haven, CT
Click here to add this to my saved trials
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults, A Remediation-based Approach
Status: Enrolling
Updated:  2/4/2016
Palo Alto Veteran's Affairs Medical Center
1328
mi
from
Palo Alto, CA
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults, A Remediation-based Approach
Status: Enrolling
Updated: 2/4/2016
Palo Alto Veteran's Affairs Medical Center
1328
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults, A Remediation-based Approach
Status: Enrolling
Updated:  2/4/2016
Posit Science Corporation
1338
mi
from
San Francisco, CA
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults, A Remediation-based Approach
Status: Enrolling
Updated: 2/4/2016
Posit Science Corporation
1338
mi
from
San Francisco, CA
Click here to add this to my saved trials
NRX-1074 in Early Course Schizophrenia
A Placebo-controlled Two-dose Trial of NRX-1074 Early in the Course of Schizophrenia
Status: Enrolling
Updated:  2/4/2016
Massachusetts General Hospital
1443
mi
from
Boston, MA
NRX-1074 in Early Course Schizophrenia
A Placebo-controlled Two-dose Trial of NRX-1074 Early in the Course of Schizophrenia
Status: Enrolling
Updated: 2/4/2016
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
NRX-1074 in Early Course Schizophrenia
A Placebo-controlled Two-dose Trial of NRX-1074 Early in the Course of Schizophrenia
Status: Enrolling
Updated:  2/4/2016
New York University Langone Medical Center/ Bellevue Hospital
1286
mi
from
New York, NY
NRX-1074 in Early Course Schizophrenia
A Placebo-controlled Two-dose Trial of NRX-1074 Early in the Course of Schizophrenia
Status: Enrolling
Updated: 2/4/2016
New York University Langone Medical Center/ Bellevue Hospital
1286
mi
from
New York, NY
Click here to add this to my saved trials
Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism
Parallel Effects of Ketamine and Schizophrenia on Neurocognitive Function
Status: Enrolling
Updated:  2/4/2016
VHA CT
1342
mi
from
West Haven, CT
Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism
Parallel Effects of Ketamine and Schizophrenia on Neurocognitive Function
Status: Enrolling
Updated: 2/4/2016
VHA CT
1342
mi
from
West Haven, CT
Click here to add this to my saved trials
Reducing Internalized Stigma in People With Serious Mental Illness
Reducing Internalized Stigma In People With Serious Mental Illness
Status: Enrolling
Updated:  2/5/2016
Washington DC VA Medical Center, Washington, DC
1127
mi
from
Washington,
Reducing Internalized Stigma in People With Serious Mental Illness
Reducing Internalized Stigma In People With Serious Mental Illness
Status: Enrolling
Updated: 2/5/2016
Washington DC VA Medical Center, Washington, DC
1127
mi
from
Washington,
Click here to add this to my saved trials
Reducing Internalized Stigma in People With Serious Mental Illness
Reducing Internalized Stigma In People With Serious Mental Illness
Status: Enrolling
Updated:  2/5/2016
VA Maryland Health Care System, Baltimore
1148
mi
from
Baltimore, MD
Reducing Internalized Stigma in People With Serious Mental Illness
Reducing Internalized Stigma In People With Serious Mental Illness
Status: Enrolling
Updated: 2/5/2016
VA Maryland Health Care System, Baltimore
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Reducing Internalized Stigma in People With Serious Mental Illness
Reducing Internalized Stigma In People With Serious Mental Illness
Status: Enrolling
Updated:  2/5/2016
Perry Point VA Medical Center VA Maryland Health Care System, Perry Point, MD
1177
mi
from
Perry Point, MD
Reducing Internalized Stigma in People With Serious Mental Illness
Reducing Internalized Stigma In People With Serious Mental Illness
Status: Enrolling
Updated: 2/5/2016
Perry Point VA Medical Center VA Maryland Health Care System, Perry Point, MD
1177
mi
from
Perry Point, MD
Click here to add this to my saved trials
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated:  2/5/2016
UCLA
1177
mi
from
Los Angeles, CA
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated: 2/5/2016
UCLA
1177
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated:  2/5/2016
Maryland Psychiatric Research Center
1142
mi
from
Catonsville, MD
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated: 2/5/2016
Maryland Psychiatric Research Center
1142
mi
from
Catonsville, MD
Click here to add this to my saved trials
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated:  2/5/2016
Massachusetts General Hospital
1443
mi
from
Boston, MA
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated: 2/5/2016
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated:  2/5/2016
Harvard Medical School
1444
mi
from
Boston, MA
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated: 2/5/2016
Harvard Medical School
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated:  2/5/2016
Washington University School of Medicine
415
mi
from
St. Louis, MO
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated: 2/5/2016
Washington University School of Medicine
415
mi
from
St. Louis, MO
Click here to add this to my saved trials
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated:  2/5/2016
Columbia University Medical Center
1286
mi
from
New York, NY
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated: 2/5/2016
Columbia University Medical Center
1286
mi
from
New York, NY
Click here to add this to my saved trials
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated:  2/5/2016
Nathan Kline Institute
1289
mi
from
Orangeburg, NY
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated: 2/5/2016
Nathan Kline Institute
1289
mi
from
Orangeburg, NY
Click here to add this to my saved trials
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated:  2/5/2016
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia
Status: Enrolling
Updated: 2/5/2016
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Click here to add this to my saved trials
Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment
Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment
Status: Enrolling
Updated:  2/5/2016
West Los Angeles Veterans Affairs Medical Center
1180
mi
from
Los Angeles, CA
Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment
Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment
Status: Enrolling
Updated: 2/5/2016
West Los Angeles Veterans Affairs Medical Center
1180
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Effect of Plasma Osmolality on Brain Glutamate
The Role of Cortical Glutamate and GABA in Brains Osmotic Regulation: A Pilot Study in Healthy Volunteers and in Patients With Schizophrenia
Status: Enrolling
Updated:  2/6/2016
34 Park Street, CMHC
1344
mi
from
New Haven, CT
The Effect of Plasma Osmolality on Brain Glutamate
The Role of Cortical Glutamate and GABA in Brains Osmotic Regulation: A Pilot Study in Healthy Volunteers and in Patients With Schizophrenia
Status: Enrolling
Updated: 2/6/2016
34 Park Street, CMHC
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
A Randomised, Double-blind, Parallel-group, Explorative Study of the Safety, Tolerability, and Pharmacokinetics of Daily Dosing Compared to Weekly Dosing of Zicronapine in Patients With Schizophrenia
Status: Enrolling
Updated:  2/22/2016
US002
1158
mi
from
Garden Grove, CA
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
A Randomised, Double-blind, Parallel-group, Explorative Study of the Safety, Tolerability, and Pharmacokinetics of Daily Dosing Compared to Weekly Dosing of Zicronapine in Patients With Schizophrenia
Status: Enrolling
Updated: 2/22/2016
US002
1158
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
A Randomised, Double-blind, Parallel-group, Explorative Study of the Safety, Tolerability, and Pharmacokinetics of Daily Dosing Compared to Weekly Dosing of Zicronapine in Patients With Schizophrenia
Status: Enrolling
Updated:  2/22/2016
US003
1140
mi
from
National City, CA
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
A Randomised, Double-blind, Parallel-group, Explorative Study of the Safety, Tolerability, and Pharmacokinetics of Daily Dosing Compared to Weekly Dosing of Zicronapine in Patients With Schizophrenia
Status: Enrolling
Updated: 2/22/2016
US003
1140
mi
from
National City, CA
Click here to add this to my saved trials
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
A Randomised, Double-blind, Parallel-group, Explorative Study of the Safety, Tolerability, and Pharmacokinetics of Daily Dosing Compared to Weekly Dosing of Zicronapine in Patients With Schizophrenia
Status: Enrolling
Updated:  2/22/2016
US004
1141
mi
from
San Diego, CA
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
A Randomised, Double-blind, Parallel-group, Explorative Study of the Safety, Tolerability, and Pharmacokinetics of Daily Dosing Compared to Weekly Dosing of Zicronapine in Patients With Schizophrenia
Status: Enrolling
Updated: 2/22/2016
US004
1141
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
A Randomised, Double-blind, Parallel-group, Explorative Study of the Safety, Tolerability, and Pharmacokinetics of Daily Dosing Compared to Weekly Dosing of Zicronapine in Patients With Schizophrenia
Status: Enrolling
Updated:  2/22/2016
US001
1120
mi
from
Rockville, MD
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
A Randomised, Double-blind, Parallel-group, Explorative Study of the Safety, Tolerability, and Pharmacokinetics of Daily Dosing Compared to Weekly Dosing of Zicronapine in Patients With Schizophrenia
Status: Enrolling
Updated: 2/22/2016
US001
1120
mi
from
Rockville, MD
Click here to add this to my saved trials
Brexpiprazole in Patients With Acute Schizophrenia
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Active-reference, Flexible-dose Study of Brexpiprazole in Patients With Acute Schizophrenia
Status: Enrolling
Updated:  2/26/2016
US009
mi
from
Escondido, CA
Brexpiprazole in Patients With Acute Schizophrenia
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Active-reference, Flexible-dose Study of Brexpiprazole in Patients With Acute Schizophrenia
Status: Enrolling
Updated: 2/26/2016
US009
mi
from
Escondido, CA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
1163
mi
from
Cerritos, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
1163
mi
from
Cerritos, CA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
1140
mi
from
Chula Vista, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
1140
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
1158
mi
from
Costa Mesa, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
1158
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
1171
mi
from
Long Beach, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
1171
mi
from
Long Beach, CA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
1331
mi
from
Oakland, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
1331
mi
from
Oakland, CA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
1136
mi
from
Oceanside, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
1136
mi
from
Oceanside, CA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
1161
mi
from
Pico Rivera, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
1161
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
1130
mi
from
Riverside, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
1130
mi
from
Riverside, CA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
1143
mi
from
San Diego, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
1143
mi
from
San Diego, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
1154
mi
from
Santa Ana, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
1154
mi
from
Santa Ana, CA
Click here to add this to my saved trials